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Secondary Metabolites 
and their Exploitation in Medicine 
Dr Alfred GRECH, Dr Alexandra BALDACCHINO and Dr Marcel TUFIGNIO 
Many of the medicinal products available today are derived from secondary 
metabolites. Plants remain the main source of such therapeutic agents but 
other sources are being explored and exploited. New and old technologies are 
being applied in the continuing quest of finding useful secondary metabolites 
of plant origin or otherwise from which newer drugs can be made. 
Introduction 
Secondary metabolites are organic compounds that are 
not directly involved in the normal growth, development 
or reproduction of organisms (Petr Karlovsky, 2008). It is 
in this sense they are called "secondary" but this does not 
imply that they are in anyway unimportant. They exert 
various biological effects, often at very low concentrations, 
and can be regarded as carriers of chemical communication 
among organisms. 
Contrary to primary metabolites, secondary metabolites 
are not ubiquitous in the living organisms which produce 
them and they are rarely conserved over a wide taxonomical 
range (c.f. primary metabolism is conserved among 
phyla and across kingdoms). Usually, they are produced 
through a long chain of intermediates involving several 
enzymes. Generally they are created from modified primary 
metabolites, or from substrates of primary metabolite origin. 
Some are produced all the time (i.e. constitutively) while 
others are produced after induction. 
By now, some 150,000 natural products are known, of 
which about 80% originate from plants. 
Functions of Secondary Metabolites 
to the Organism 
The function of secondary metabolites is usually of 
an ecological nature. Some are used by the organism to 
defend itself against its predators, parasites and diseases. 
Others are used for interspecies competition, or to facilitate 
the reproductive processes e.g the coloring agents and the 
attractive smells of flowers are usually secondary metabolites. 
They may also function in such other processes as immunity, 
anti-herbivory, maintaining symbiotic associations or 
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communication between organisms (e.g. VOCs = volatile 
organic compounds; bacterial autoinducers). 
Bacterial cells use secondary metabolites to chemically 
communicate with each other in a process called quorum 
sensing (QS). Quorum sensing in bacteria is the regulation 
of gene expression as a function of the cell-population 
density. The bacteria produce and release chemical signal 
molecules called autoinducers. Usually as the bacterial 
population density increases, the concentration of the signal 
molecules increases as well. When the bacterial population 
reaches a critical level called the quorum, the bacteria 
respond and modulate certain gene expression (like genes 
coding for virulence) almost simultaneously. 
Gram-positive and Gram-negative bacteria use 
quorum sensing to regulate a diverse array of physiological 
activities such as symbiosis, competence, conjugation, 
antibiotic production, motility, sporulation, virulence and 
biofilm formation. In general, Gram-negative bacteria use 
acylated homoserine lac tones (AHLs) as autoinducers, 
and Gram-positive bacteria use processed oligo-peptides 
to communicate . This cell-to-cell communication via 
autoinducers occurs both within and between bacterial 
species. Indeed, furanosyl borate diester has been found 
to be employed by certain bacteria for interspecies 
communication (Chen et al. 2002). 
Research is showing that with quorum sensing, the 
bacteria are becoming 'multicellular'. And doctors should 
no longer think that bacteria are asocial, single cells. They 
are individual cells but they act in communities. Researchers 
in various labs all over the world are now trying to find 
out exactly how bacteria chemically 'talk' to each other. 
Hopefully, they will know how to control and manipulate 
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Table I 
Medical Use Medicinal agent Source 
Anti-tumour Vincristine, VinblastineTaxol, Ursolic acid Catharanthus roseus, Taxus sp., Lichens 
Discodermolide Discodermia dissoluta 
Antibiotic Abyssomicin, Vancomycin, Streptomycin Bacitracin, Actinobacteria, Bacillus subtilis 
Penicillin, Erythromycin, Penicillium, Saccharopolyspora erythraea, 
Usnic acid Lichens 
Antiviral Depsides, Depsidones Virsenic acid, Stictic acid Lichens 
Chlorophaeic acid, Podophyllin Podophyllium 
Antimalarial Quinine Cinchona ledgeriana 
Cardiotonic Digoxin Digitalis lanata 
An tihypertensive Reserpine, Ajmalicine Rauwolfia serpentina, Catharanthus roseus 
AnalgesiC Morphine Papaver somniferum 
Anti-pyretic Salicylic acid Salix 
Anti-inflammatory 
Anti-cholinergic Atropine, Hyoscyamine, Scopolamine Atropa belladonna, Hyoscyamus niger 
Cholinergic Pilocarpine 
Anti-gout Cochicine 
Antifertility Steroids from Diosgenin 
Anti-tussive, Antidiarrheal Codeine 
quorum sensing and tailor make anti-quorum sensing drugs. 
One line of research is the demonstration that certain plants 
and red algae are able to mimic QS signals produced by 
several bacteria by secreting compounds that structurally 
mimic the bacterial QS molecules (Newton and Fray 2004; 
Bauer and Mathesius 2004). Specifically, the marine red 
alga Delisea pulchra produces halogenated furanones 
which act as QS 'mimic' compounds. These halogenated 
furanones have a similar structure to AHLs. Interestingly, 
such furanones inhibit AHL-regulated behaviours in several 
bacteria (Teplitski et al. 2000) . 
Medical Uses of Exploited 
Secondary Metabolites 
The following valid and instructive example shows the 
potential of exploiting secondary metabolites for medical 
use. Doctors are worried that unless scientists find novel 
antibiotics within a short time, they would find themselves 
back in the era oflife-threatening bacterial infections. A case 
in point is the superbug, MRSA, which is now resistant to 
most antibiotics. By exploiting marine microbes (specifically, 
a group of bacteria called Actinobacteria) , researchers have 
come across a new class of antibiotics. Usually, such bacteria 







came from soils and researchers believed that there were 
no marine species of Actinobacteria. But Actinobacteria are 
also found in seawater sediments, from continental shelves 
to the abyssal depths. Indeed, a marine sediment may 
contain more than 1000 new species. Scientists have found 
a bacterium from such a sediment at a depth of 300 metres 
in a bay in Japan. This bacterium produces a secondary 
metabolite that acts as an antibiotic to control the growth 
of other micro-organisms in its niche. This antibiotic has 
been rightly named abyssomicin. Investigations and tests 
on abyssomicin are shOwing promising results in that it kills 
MRSA. Also, by studying the mode of action of abyssomicin 
it has been found that it disrupts pABA synthesis. Therefore, 
this may also make abyssomicin a potential anti-malarial 
drug. 
Some of the medical uses of some secondary metabolites 
are shown in Table 1 above. 
Some Specific Examples of Exploitation 
of Secondary Metabolites 
From Plants 
Plants have been used in the treatment of cancer for 
over 3500 years (Harrwell,1967). This is evidenced in the 
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folklore of many countries. For example the Chinese used 
podophyllum leaves and many other countries used the 
juice of Bittersweet (Solanum dulcamara) to treat cancers, 
tumors and warts. But it is only since 1959 that a systematic 
effort has been made to screen crude plant extracts for their 
inhibitory activity against tumour systems. 
The number of medicines used in chemotherapy is 
around 20. These comprise synthetic and natural drugs 
(Lee, 1999). Most of the active principles act upon DNA by 
modifying its chemical and physical nature. On the basis 
of mechanisms of action the antitumour agents can be 
broadly categorized in 4 groups: Cl) alkylating agents, (2) 
antimetabolites, (3) mitotic inhibitors (spindle fibre toxins) 
and (4) intercalating agents. Caryolysine was among the first 
alkylating antitumoral agent in the class of nitrogen mustard 
used for the treatment of human cancers. Chlorambucil, 
melphalan and mannomustine are other alkylating products 
that were developed later. Fluorouracil and methorexate 
are examples of antimetabolites, while colchicine, taxol 
and vinblastine (a vinca alkaloid) are mitotic inhibitors. 
Quinine, quinacrine, ellipticine, ethidium bromide, nitidine 
and actinomycin-D are all examples of DNA intercalating 
agents. Of these taxol is the latest and is obtained from the 
bark of yew, Taxus. Taxol is used for the treatment of breast, 
ovarian, lung, bladder, prostrate, melanoma, esophageal, as 
well as other types of solid cancers. 
Other medically exploited secondary metabolites 
derived from plants include atropine, codeine, morphine, 
and digoxin. Atropine is extracted from deadly nightshade 
(Atropa belladonna), jimsonweed (Datura stramonium), 
mandrake (Mandragora officinarum) and other plants of the 
family Solanaceae. Morphine is the principal active agent 
in opium and other poppy saps like Papaver bracteatum. It 
was the first alkaloid isolated from a plant source, and was 
named morphium after Morpheus, the Greek god of dreams. 
Codeine (methylmorphine) is also found in opium and while 
it can be extracted from opium, most codeine is synthesized 
from morphine through the process of O-methylation. 
Digoxin (Digitalis) is a cardiac glycoside extracted from the 
foxglove plant, Digitalis lanata. 
From Bacteria 
Vancomycin is a glycopeptide antibiotic derived from 
the Actinobacteria species Amycolatopsis orientalis. It was 
first isolated from a soil sample collected from the interior 
jungles of Borneo by a missionary. 
Streptomycin is another antibiotic, the first of a class of 
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drugs called aminoglycosides to be discovered. It was the 
first antibiotic remedy for tuberculosis. It is derived from 
the actinobacterium Streptomyces griseus. Neomycin is also 
an aminoglycoside antibiotic that is found in many topical 
medications such as creams, ointments and eyedrops. 
It is produced naturally by the bacterium Streptomyces 
fradiae. 
Another topical antibiotic is Bacitracin. It is produced 
by Bacillus subtilis . 
From Fungi 
Fungi also offer a huge source of pharmaceutically 
useful molecules. For the fungi the discovery of penicillin 
marked a new era. Penicillin is an antibiotic that is derived 
from the fungus Penicillium. Another useful antibiotic 
is erythromycin. It is produced from a strain of the 
actinomycete Saccharopolyspora erythraea found in soil. 
The genus Claviceps is a fungus that is parasitic on 
certain grains and grasses. In winter the fungus forms a 
sclerotium usually referred to as an 'ergot'. These ergots are 
hard, black tuber-like bodies which consist of a compact 
mass of hyphae. Such ergots produce up to 40 different 
alkaloids. The main ergo t alkaloids are ergotamine, 
ergocornine, ergocristine, ergocryptine, ergometrine and 
agroclavine. If ergot alkaloid-containing grasses and cereals 
are eaten, ergotism results ("St. Anthony's Fire"). 
Some of the ergot alkaloids have been medically 
exploited. Historically, controlled doses of ergot were used 
to induce abortions and to stop maternal bleeding after 
childbirth. Nowadays, one also finds nasal drops containing 
ergometrin (Methergin) to stop postnatal bleeding; Cafergot 
(containing caffeine and ergotamine or ergoline) to treat 
migraine headaches. Another two important ergot-derived 
drugs are Pergolide and Cabergoline. Pergolide (Permax) is 
a dopamine receptor agonist and is used for the treatment 
of Parkinson's disease. Pergolide products were removed 
from the market in 2007 because of the risk of serious 
damage to patients' heart valves. Nowadays, if indicated 
the patient should be regularly reassessed for any fibrotic 
reactions and valvulopathy. Cabergoline (Dostinex) is also a 
dopamine receptor agonist. It is indicated for the treatment 
of hyperprolactinemic disorders. 
From Lichens 
Lichens are associations between a fungus (the 
mycobiont) and a primitive photosynthetic organism 
(the photobiont). The latter is either a green alga or a 
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cyanobacteria. Approximately 700 secondary metabolites 
have been identified in lichens. Many of these compounds 
are the result of the symbiosis. Indeed, the majority of 
the organic compounds formed in lichens are secondary 
metabolites produced by the fungal partner (Huneck and 
Yoshimura, 1996). 
Lichens have a long history of usage in herbal 
medicines. Even though their therapeutic potential has not 
been yet fully explored, the following biological activities of 
some lichen secondary metabolites have been investigated 
and exploited. 
Usnic acid has antibiotic activity. Compositions 
containing usnic acid or its derivatives are used for 
therapeutic control of dental caries, particularly for 
the preventive treatment of cariogenic dental plaque. 
Usnic acid is bacteriostatic against the gram-positive 
Streptococcus mutans which is the primary pathogen in 
cariogenic lesions. Many tooth pastes and mouthwashes 
used for dental and oral cavity medications contain usnic 
acid. 
Ursolic acid has anti-cancer activity. The use of ursolic 
acid for the manufacture of an anticancer agent that 
suppresses metastasis has been patented (Ishikawa et aI, 
1997). Other lichen secondary metabolites that exhibit 
antitumoral effects include: nephrostemic acid, polyporic 
acid and its derivatives and evemic acid. 
Depsides and depsidones have antiviral-activity 
against HIV virus. They inhibit HIV-integrase and are being 
investigated as potential AIDS treatment. Virsenic acid, 
stictic acid and chlorophaeic acid also show important 
effects against HIV-1 integrase. (Neamati et aI. , 1996). 
The screening of crude extracts of numerous species 
of the lichen family Graphidaceae have demonstrated 
inhibition of the enzyme tyrosinase. Tyrosinase inhibitors 
have become important as cosmetic and medicinal 
products, primarily to control melanin pigmentation. 
It has been shown that some secondary metabolites 
from lichens (e.g. divaricatic acid, atranorin) protect 
against oxidative damage by inhibiting the formation 
of free radicals and/or trapping reactive oxygen species. 
(Marante et aI., 2003). 
Other lichen products have analgesic , anti-
inflammatory, or anti-pyretic activities. For example 
chrysophanol has been shown to be a potent anti-
proliferative and anti-inflammatory agent in the treatment 
of psoriasis (Muller, 2001). 
Maltese Family Doctor It-Tabib tal-Familja 
Pannarin and chloropannarin have been shown to have 
antiprotozoal activity. 
From a Sponge 
Discodermolide is a recently discovered polyketide 
natural product found to be a potent inhibitor of tumor cell 
growth by hyper-stabilizing microtubules. It was first isolated 
in 1990 from the Caribbean marine sponge Discodermia 
dissoluta. Discodermolide also has immunosuppressive and 
antifungal activities. Several preclinical drug development 
programs are ongoing. 
Current Research 
on Secondary Metabolites 
Production of Secondary Metabolites by 
Bioconversion and Precursor Feeding 
Plant cells are omnipotential, meaning that all the 
genetic information present in the plant is principally 
available in each cell . Hence theoretically, genes that 
encode enzymes ofbiosynthetic pathways can be brought to 
express themselves. It is thus feasible to produce most plant 
secondary metabolites using in vitro grown cultures. The 
successful production of antibiotics by fungi and bacteria 
was the stimulus for the initial plant biotechnologists to have 
a try with in vitro plant cell cultures. But it soon became 
clear that plant cell cultures do not always accumulate either 
qualitatively or quantitatively the same compounds found in 
the parent plant from which they were established. Because 
of this only a very limited number of secondary metabolites 
can be produced commerCially by plant cells on a larger 
scale in bioreactors. High production rates are only feasible 
for compounds with a simple chemical structure, such as 
L-DOPA (an important anti-Parkins on drug). 
Unfortunately, pharmacologically active compounds 
have a more complex chemical structure e.g. podophyllotoxin 
and camptothecine which exert strong cytotoxic properties. 
Artemisin, a very potent new antimalarial drug and also 
the new cytostatic agent paclitaxel, have been produced 
in low amounts by Taxus cell cultures, progress is slowly 
being made and precursor feeding and bioconversion are 
very promising. 
If the concentration of a compound which is an 
intermediate in a biosynthetic pathway is increased, this 
may increase the yield of the final product of the pathway. 
This is the basis of the precursor feeding approach. 
Bioconversion is the modification of added precursors 
(also called substrates) into more valuable products using 
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enzyme catalysis. The systems used for bioconversion are 
en freely suspended plant cells (ii) immobilized plant cells 
and (iii) enzyme preparations. 
Freely suspended cells are the most simple bioconversion 
systems, since precursors can be supplied directly to the 
cultures. The cell wall and cell membrane are the only 
barriers a precursor meets. The best way is to use plant cells 
that can do a one-step bioconversion but unfortunately the 
precursor often undergoes more than one bioconversion, 
resulting in complex mixtures of products. It can also be 
metabolized via unknown mechanisms. Nevertheless, a 
number of one-step bioconversions by freely suspended 
cells have been done . For example papaverine has been 
bioconverted using free cell suspensions of Glycyrrhiza 
glabra. 
An immobilized plant cells system entails either 
entrapment of cells or immobilisation of cells. Immobilisation 
of the plant cells can be done by adsorption onto a support 
material. Entrapment methods include gel entrapment by 
ionic network formation and entrapment in performed 
structures (N ovais, 1988) . The most widely used approach 
is entrapment by ionic network formation , especially in the 
form of alginate beads. 
Some successfully applied one-step bioconversions 
by immobilized cells have been done. For example the 
bioconversion of the precursor codenione into codeine using 
Papaver somniferum or the bioconversion ofL-tyrosine into 
L-DOPA using Mucuna pruriens. Immobilized cells derived 
from various lichens have also been employed to produce 
useful secondary metabolites (Vincente et aI., 2003) . 
Enzymes from plant cells are also being used to convert 
foreign precursors, intermediates that are not normally 
biosynthesized in the plants from which the cultures are 
derived (Kutney, 1996: Suga and Hirata, 1990). 
Bioconversions and precursor feeding are yielding new 
drugs but they are also being applied for the improvement of 
currently used drugs. Hydroxylations and gylcosylations or 
a combination of both are most suitable for this purpose. 
Recombinant DNA technology 
Plant cells often make low quantities of the desired 
enzyme, resulting in low bioconversion rates. A solution 
may be found in the transfer of plant genes, which encode 
the enzyme into a bacterial (e.g. E.coli) or fungal cell (yeast) 
and more, recently, into insect cells. The idea is to bring the 
gene to overexpression in a preferably rapidly growing host 
cell, resulting in a high production of the desired enzyme 
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(Overbeck and Verrips, 1992). This expression of genes 
encoding plant enzymes in a foreign host cell is termed 
heterologous expression: a gene is transferred from one 
cell species, a plant cell, to another cell species, the host 
cell (fungal or insect cell). This heterologous expression is 
also being tried (with some success) for the production of 
certain lichen metabolites. Recombinant DNA technology 
has not yet reached the stage at which large numbers of 
foreign genes can be transferred to any host cell and then 
coordinately expressed. This implies that the problems 
regarding the expression of more complex pathways (which 
usually have many enzymes) under in-vitro circumstances 
are not likely to be solved in the near future. 
With all the above problems, still, the culture of plant 
cells or otherwise is feasible and can be used to produce 
significant amounts of secondary metabolites. For the 
development of an industrial process, the crucial question 
is its economic feasibility. At the time it is only for a small 
number of high-value compounds that this is economically 
feasible. However, research and many experiments are 
being done to improve productivity of other secondary 
metabolites from stable, high-yielding cell lines. The 
production of secondary metabolites on an industrial 
scale using bioreactor system designs is important because 
indiscriminate removal of plants or otherwise from the 
wild to meet the high demand of medicine for the ever-
increasing human population, is making such wild sources 
endangered. A case in point is the exploitation of the Taxus 
tree for taxol. Taxus is a small tree that grows very slowly. 
Taxol is derived from its bark and its extraction leads to 
death of the tree. It is estimated that about 50kg of taxol will 
be required every year for the treatment of approximately 
12,500 women in the USA alone. The present world 
demand may touch 250kg per year. Generally 30kg of taxol 
are obtained from 42,000 trees. So with some calculations 
this means that at least three Taxus plants are needed for 
one patient. Such a large number of plants are not available 
from the wild population. 
Metabolomics 
The set of metabolites synthesized by an organism 
constitute its metabolome. Metabolomics is the quantitative 
and qualitative study of all the metabolites present in a cell. 
By comparing the metabolic profile of a cell producing 
metabolites in high quantity to a similar cell that is not 
producing these metabolites , differences in gene expression 
is being recorded. Such studies form part of functional 
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genomics and it is helping in the identification of genes 
which are involved in product formation. It is also elucidating 
key steps and bottlenecks of metabolite synthesis. Metabolic 
profiling of the wild type, mutant and transgenic organism, 
is providing useful data in metabolic fingerprinting. 
Indeed, it is becoming possible to link metabolic changes in 
biochemical pathways to the enzymes involved, and then to 
the underlying genetic alterations. 
Such metabolic studies are yielding huge data sets that 
need to be analyzed and stored. With replications and 
various samples taken during experiments, the number 
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